—

Laboratorios Farmaceuticos ROVI (ROVI.MC) — the peer cohort

As of 2026-11-18 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Laboratorios Farmaceuticos ROVI ranks 1 of 7 in its cohort on the Closelooknet composite (63/100) — the highest reading in the cohort.

NameCompositeMomentumQualityValuationSignalOff 52w high
ROVI.MC Laboratorios Farmaceuticos ROVI 63 61 74 42 info 20.7%
LNTH Lantheus Holdings Inc 59 74 73 53 ok 8.8%
IRWD Ironwood Pharmaceuticals Inc 58 74 77 82 info 17.3%
KNSA Kiniksa Pharmaceuticals Ltd 58 95 61 17 ok 4.3%
GALDY GALDERMA GROUP AG 56 71 59 21 ok 7.1%
BHC.TO Bausch Health Companies Inc 55 96 50 85 ok 1.1%
FAGR.BR Fagron NV 55 69 56 56 ok 3%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-18

Quick answers

Who are Laboratorios Farmaceuticos ROVI's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Lantheus Holdings Inc (LNTH), Ironwood Pharmaceuticals Inc (IRWD), Kiniksa Pharmaceuticals Ltd (KNSA), GALDERMA GROUP AG (GALDY), Bausch Health Companies Inc (BHC.TO), Fagron NV (FAGR.BR), as of 2026-11-18.

How does ROVI.MC score against its peers?

Laboratorios Farmaceuticos ROVI's composite reads 63/100, ranking 1 of 7 in its cohort as of 2026-11-18 — the highest in the cohort. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.